MECOM: a bioinformatics and experimentally identified marker for the diagnosis and prognosis of lung adenocarcinoma

Conclusion: MECOM may contribute to independently identifying LUAD patients, particularly in advanced stages.PMID:38440890 | DOI:10.2217/bmm-2023-0600

Source: Future Medicine: Biomarkers in Medicine - March 5, 2024 Category: Internal Medicine Authors: Anqi Li Meng Li Jing Wang Jiejun Zhou Tian Yang Meng Fan Kun Zhang Hengxing Gao Hui Ren Mingwei Chen Source Type: research